Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 31 Mar 2026 for UNITED THERAPEUTICS Corp, €136k. Read the official filing
Filing timeline
BuySaleChristopher Causey
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher Causey: trading record in brief
Christopher Causey is a declared insider of UNITED THERAPEUTICS Corp (senior executive), with filings sourced from SEC (Form 4). The record holds 36 filings, for trades running from 7 January 2016 to 30 March 2026.
On the market, this insider has only sold: 4 sales, €2.1M in total. The rest of the record consists of 25 option exercises. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 31 March 2026, the filings show an open-market sale worth €686k in UNITED THERAPEUTICS Corp. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Causey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
1,300 shares@ US$119.762.3% of flowCommon StockSEC:0001237334-26-000005:0
1,300 shares@ US$604.6411.6% of flowCommon StockSEC:0001237334-26-000005:1
20 shares@ US$119.760.0% of flowCommon StockSEC:0001237334-26-000004:0
1,000 shares@ US$119.761.5% of flowCommon StockSEC:0001237334-26-000003:0
1,000 shares@ US$119.761.5% of flowCommon StockSEC:0001237334-26-000002:0
1,000 shares@ US$119.761.5% of flowCommon StockSEC:0001237334-26-000001:0
450 shares0Common StockSEC:0001237334-25-000006:0
225 shares0Common StockSEC:0001237334-25-000005:0
1,000 shares@ US$119.761.6% of flowCommon StockSEC:0001237334-25-000004:0
3,000 shares@ US$132.305.5% of flowCommon StockSEC:0001237334-25-000003:0
1,190 shares0Common StockSEC:0001562180-25-005513:0
510 shares@ US$376.62813.4% of flowCommon StockSEC:0001415889-24-025976:0
1,210 shares@ US$132.302.7% of flowCommon StockSEC:0001415889-24-022034:0
3,000 shares@ US$112.146.0% of flowCommon StockSEC:0001415889-24-017646:0
2,000 shares@ US$112.144.0% of flowCommon StockSEC:0001415889-24-016933:0
2,000 shares@ US$112.143.9% of flowCommon StockSEC:0001415889-24-013353:0
2,240 shares@ US$112.144.4% of flowCommon StockSEC:0001415889-24-012329:0
400 shares@ US$255.001.8% of flowCommon StockSEC:0001415889-23-016597:0
3,000 shares@ US$175.439.3% of flowCommon StockSEC:0001415889-23-016417:0
1,750 shares0Common StockSEC:0001415889-23-010945:0
1,000 shares@ US$175.433.1% of flowCommon StockSEC:0001415889-23-000085:0
2,500 shares@ US$175.438.4% of flowCommon StockSEC:0001415889-22-011052:0
3,500 shares@ US$175.4311.7% of flowCommon StockSEC:0001415889-22-009057:0
2,160 shares0Common StockSEC:0001415889-22-007607:0
5,000 shares@ US$236.7921.3% of flowCommon StockSEC:0001415889-22-007024:1
25 of 36 declarations
